Ask AI
CaDAnCe 101 CLL
CaDAnCe-101: Update From a Phase I Study of BTK Degrader Tacabrutideg (BGB-16673) in R/R CLL/SLL

Released: July 07, 2026

Activity

Progress
1
Course Completed
Activity Information

Released: July 07, 2026